Press Releases Items Per Page 102550 Year None2022202120202019 Date Title View January 10, 2022 Neoleukin Therapeutics Announces Clinical Collaboration with Merck to Evaluate NL-201 in Combination with KEYTRUDA® (pembrolizumab) January 10, 2022 Neoleukin Therapeutics Presenting at H.C. Wainwright BIOCONNECT Virtual Conference Pagination First page « first Previous page ‹ previous Page 1 Current page 2